Bastide Le Confort Médical SA (0IP1.L)
EUR 26.45
(2.92%)
EUR 26.45
(2.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 110.32 Million EUR | 30.16% |
| 2023 | 82.36 Million EUR | 3.59% |
| 2022 | 79.51 Million EUR | 9.26% |
| 2021 | 80.18 Million EUR | 9.15% |
| 2020 | 66.66 Million EUR | 4.9% |
| 2019 | 63.55 Million EUR | 28.6% |
| 2018 | 49.42 Million EUR | 35.83% |
| 2017 | 36.38 Million EUR | 3.91% |
| 2016 | 35.01 Million EUR | 9.73% |
| 2015 | 31.91 Million EUR | 18.96% |
| 2014 | 26.82 Million EUR | 21.89% |
| 2013 | 22 Million EUR | 12.81% |
| 2012 | 19.5 Million EUR | 14.26% |
| 2011 | 16.93 Million EUR | 7.51% |
| 2010 | 15.88 Million EUR | 14.26% |
| 2009 | 13.89 Million EUR | -23.14% |
| 2008 | 17.94 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 41.41 Million EUR | 0.0% |
| 2024 Q4 | 56.28 Million EUR | 0.0% |
| 2023 Q2 | 39.24 Million EUR | 0.0% |
| 2023 FY | - EUR | 3.59% |
| 2023 Q4 | 43.12 Million EUR | 0.0% |
| 2022 FY | - EUR | 9.26% |
| 2022 Q4 | 41.55 Million EUR | 0.0% |
| 2022 Q2 | 37.95 Million EUR | 0.0% |
| 2021 Q4 | 37.53 Million EUR | 0.0% |
| 2021 Q2 | 33.49 Million EUR | 0.0% |
| 2021 FY | - EUR | 9.15% |
| 2020 Q2 | 31.63 Million EUR | 0.0% |
| 2020 Q4 | 35.03 Million EUR | 0.0% |
| 2020 FY | - EUR | 4.9% |
| 2019 Q4 | 32.44 Million EUR | 0.0% |
| 2019 FY | - EUR | 28.6% |
| 2019 Q2 | 31.1 Million EUR | 0.0% |
| 2018 FY | - EUR | 35.83% |
| 2018 Q4 | 25.36 Million EUR | 0.0% |
| 2018 Q2 | 24.06 Million EUR | 0.0% |
| 2017 Q2 | 20.52 Million EUR | 0.0% |
| 2017 FY | - EUR | 3.91% |
| 2017 Q4 | 15.85 Million EUR | 0.0% |
| 2016 FY | - EUR | 9.73% |
| 2016 Q2 | 17.26 Million EUR | 0.0% |
| 2016 Q4 | 17.75 Million EUR | 0.0% |
| 2015 FY | - EUR | 18.96% |
| 2015 Q2 | 16.17 Million EUR | 0.0% |
| 2015 Q4 | 15.73 Million EUR | 0.0% |
| 2014 FY | - EUR | 21.89% |
| 2014 Q4 | 13.76 Million EUR | 0.0% |
| 2014 Q2 | 13.06 Million EUR | 0.0% |
| 2013 Q4 | 11.01 Million EUR | 0.0% |
| 2013 Q2 | 10.99 Million EUR | 0.0% |
| 2013 FY | - EUR | 12.81% |
| 2012 Q4 | 4.86 Million EUR | 0.0% |
| 2012 Q3 | 4.86 Million EUR | 0.0% |
| 2012 FY | - EUR | 14.26% |
| 2012 Q2 | 4.86 Million EUR | 14.12% |
| 2012 Q1 | 4.26 Million EUR | 0.0% |
| 2011 Q1 | 3.63 Million EUR | 0.0% |
| 2011 Q2 | 4.26 Million EUR | 17.12% |
| 2011 Q3 | 4.26 Million EUR | 0.0% |
| 2011 Q4 | 4.26 Million EUR | 0.0% |
| 2011 FY | - EUR | 7.51% |
| 2010 Q3 | 3.63 Million EUR | 0.0% |
| 2010 Q4 | 3.63 Million EUR | 0.0% |
| 2010 Q2 | 3.63 Million EUR | 16.75% |
| 2010 FY | - EUR | 14.26% |
| 2010 Q1 | 3.11 Million EUR | 0.0% |
| 2009 Q4 | 3.11 Million EUR | 0.0% |
| 2009 Q3 | 3.11 Million EUR | 0.0% |
| 2009 Q2 | 3.11 Million EUR | -29.62% |
| 2009 Q1 | 4.42 Million EUR | 0.0% |
| 2009 FY | - EUR | -23.14% |
| 2008 FY | - EUR | 0.0% |
| 2008 Q4 | 4.42 Million EUR | 0.0% |
| 2008 Q3 | 4.42 Million EUR | 0.0% |
| 2008 Q2 | 4.42 Million EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cegedim SA | 95.25 Million EUR | -15.825% |
| Guerbet SA | 90.09 Million EUR | -22.454% |
| Nexus AG | 53.43 Million EUR | -106.479% |
| Revenio Group Oyj | 30.09 Million EUR | -266.647% |
| Drägerwerk AG & Co. KGaA | 318.33 Million EUR | 65.343% |
| Sartorius Aktiengesellschaft | 811.2 Million EUR | 86.4% |
| LNA Santé SA | 144.63 Million EUR | 23.722% |
| Siemens Healthineers AG | 4.22 Billion EUR | 97.389% |
| Medios AG | 52.81 Million EUR | -108.884% |
| Equasens Société anonyme | 71.29 Million EUR | -54.734% |
| Stratec SE | 39.82 Million EUR | -177.05% |